Heart Failure Epidemiology Forecast 2026-2035

The rising cardiovascular risk factors and an aging population continue to expand the global burden of heart failure. According to the Centers for Disease Control and Prevention, in 2023, heart failure was mentioned on 452,573 death certificates, accounting for 14.6% of all deaths., underscoring significant clinical and healthcare implications. The heart failure epidemiology forecast emphasizes growing attention toward early diagnosis, preventive cardiology, and integrated disease management strategies to address the increasing long-term burden of heart failure globally.

Heart Failure Epidemiology Forecast Report Coverage

The analyst's “Heart Failure Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of heart failure. It projects the future incidence and prevalence rates of heart failure cases across various populations. The study covers age, gender, and type as major determinants of the heart failure population. The report highlights patterns in the prevalence of heart failure over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on heart failure epidemiology in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Heart Failure Understanding: Disease Overview

Heart failure is a chronic and progressive cardiovascular condition in which the heart is unable to pump sufficient blood to meet the body’s metabolic demands. The disorder typically develops because of structural or functional cardiac abnormalities, including coronary artery disease, hypertension, cardiomyopathy, or valvular heart disease. Heart failure is commonly classified based on left ventricular ejection fraction into reduced, preserved, or mildly reduced categories. Patients often experience symptoms such as shortness of breath, fatigue, fluid retention, and reduced exercise tolerance. The condition is associated with significant morbidity, mortality, and healthcare utilization worldwide.

Heart Failure Epidemiology Perspective

The heart failure epidemiology division offers information on the patient pool from history to the present, as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the heart failure epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for heart failure and their trends. The heart failure detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to the Heart Failure Society of America Annual Report, approximately 60 million people worldwide are living with heart failure, representing nearly 1-3% of the global population, reflecting a growing cardiovascular disease burden.
• As reported in the Heart Failure Society of America Annual Report, heart failure prevalence rises substantially with age, particularly after 65 years, with the highest disease burden observed among individuals aged 75 years and older, highlighting the strong association between aging and heart failure risk.
• According to the Global Cardiology Academy, in the United States, epidemiological estimates show slightly higher heart failure prevalence in women, with about 35 million male cases compared with nearly 29 million male cases.
• Ethnicity-based analyses show higher heart failure prevalence among non-Hispanic Black populations, followed by White and Hispanic groups, while Asian studies report a prevalence rate of 6.84% in Southeast Asians.

Country-wise Heart Failure Epidemiology Segment

The heart failure epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

In the United States, heart failure remains a major cardiovascular health concern with a steadily rising disease burden. According to the Heart Failure Society of America Annual Report, approximately 6.7 million Americans aged 20 years and older are currently living with heart failure, reflecting the significant prevalence of this chronic condition. Estimates suggest that cases may rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. Across Europe, heart failure epidemiology varies significantly; according to the Global Cardiology Academy, incidence ranges from 1.99 per 1000 person-years in Italy to 6.55 in Germany, while the United Kingdom reported a 7% decline between 2002 and 2014. Epidemiological projections indicate that the number of affected individuals is expected to increase substantially over the coming decades, underscoring the expanding clinical and healthcare burden associated with heart failure across the country in the future.

Heart Failure: Treatment Overview

Heart failure treatment aims to relieve symptoms, improve cardiac function, reduce hospitalizations, and prolong survival. Pharmacological therapy commonly includes angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter-2 inhibitors. Diuretics are frequently prescribed to manage fluid retention and congestion. For selected patients, device-based therapies such as implantable cardioverter-defibrillators and cardiac resynchronization therapy may be recommended. Advanced treatment options include ventricular assist devices and heart transplantation for patients with end-stage disease. Lifestyle modifications, including dietary sodium restriction, regular monitoring, and physical activity, remain critical components of comprehensive management.

Key Questions Answered

• What are the key findings of heart failure epidemiology in the 8 major markets?
• What will be the total number of patients with heart failure across the 8 major markets during the forecast period?
• What was the country-wise heart failure epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of cases of heart failure during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of heart failure during the forecast period of 2026-2035?
• What are the currently available treatments for heart failure?
• What are the disease risks, signs, symptoms, and unmet needs of heart failure?

Scope of the Heart Failure Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of heart failure based on several factors.
• Heart Failure Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The heart failure report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.